(S)-tert-butyl 6-hydroxy-1,4-oxazepane-4-carboxylate, 95.0%, 100mg

3,5-Bis(trifluoromethyl)benzylamine>95.0%(GC)(W)1g

1-(4-Hydroxy-3-methoxyphenyl)butan-1-one, 97.0%, 250mg

1,2,4-Triazole-3-carboxamide>97.0%(HPLC)(N)5g

1-(4-chloro-3-nitrophenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

beta-Ionone>95.0%(GC)100mL

5-(Bromomethyl)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, 98%, 1g

(2S,3S)-3-((tert-Butoxycarbonyl)amino)-2-hydroxy-3-(naphthalen-2-yl)propanoic acid, 95.0%, 250mg

2-Chlorophenol , ≥98%, for synthesis, 250 ml, glass packaging

Ethyl 2-chloroquinazoline-4-carboxylate, 95.0%, 250mg

4-[1-(4-Hydroxy-3,5-dimethylphenyl)-1-methylethyl]-2,6-dimethylphenol, 97.0%, 25g

methyl 5-bromo-4,6-difluoro-1H-indole-3-carboxylate, 95.0%, 1g

5-Fluorothiazol-2-amine hydrochloride, 95.0%, 250mg